14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
SSK vs BSOL: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, BSOL (BSOL) is the stronger overall head-to-head candidate over REX-Osprey SOL + Staking ETF (SSK) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). SSK carries a Unified Composite Score of 40.7/100 (SELL) at $9.62 (N/M Forward P/E, N/A operating margin), whereas BSOL carries 42.9/100 (HOLD) at $9.88 (N/M Forward P/E, N/A operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SSK vs BSOL. Trailing 12-month operating profitability (SSK N/A vs BSOL N/A) and valuation multiples (SSK N/M vs BSOL N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ SSK vs BSOL Key Questions & Quantitative Answers
As of Nov 16, 2026, BSOL (BSOL) is the stronger overall head-to-head candidate over REX-Osprey SOL + Staking ETF (SSK) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). SSK carries a Unified Composite Score of 40.7/100 (SELL) at $9.62 (N/M Forward P/E, N/A operating margin), whereas BSOL carries 42.9/100 (HOLD) at $9.88 (N/M Forward P/E, N/A operating margin). Technically, SSK sits in a Neutral phase (RSI 20.8, UNCLASSIFIED options structure) and BSOL sits in a Neutral phase (RSI 21.4, UNCLASSIFIED options structure).
SSK and BSOL split Growth & Scale metrics: SSK posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with BSOL at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, SSK generates N/A in USD-normalized revenue versus N/A for BSOL. In operating R&D and SG&A reinvestment, SSK deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for BSOL.
SSK and BSOL trade at balanced relative valuation multiples. SSK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas BSOL trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SSK (N/A ROE) versus BSOL (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, SSK carries 70.4% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.80β · 53% Vol realized risk). By comparison, BSOL carries 91.0% implied volatility (30th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.81β · 54% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.